Analgesics (Pharmacies) - Switzerland

Revenue in the Analgesics market is projected to reach US$175.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.21%, resulting in a market volume of US$225.90m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$19.80 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Switzerland has been experiencing steady growth in recent years.

Customer preferences: Swiss customers have shown a strong preference for analgesic products purchased from pharmacies rather than other retail channels. This preference can be attributed to the trust and confidence that Swiss consumers have in the expertise and quality of products offered by pharmacies. Additionally, pharmacies in Switzerland are known for providing personalized advice and recommendations to customers, which further enhances their appeal as a preferred channel for analgesics.

Trends in the market: One notable trend in the Swiss analgesics market is the growing demand for natural and alternative pain relief products. Swiss consumers are increasingly seeking out analgesics that are derived from natural ingredients and have fewer side effects. This trend aligns with the broader global movement towards natural and organic products, as consumers become more conscious of their health and wellness. Another trend in the market is the increasing popularity of online pharmacies. Swiss consumers are embracing the convenience and accessibility offered by online platforms, which allow them to purchase analgesics from the comfort of their own homes. Online pharmacies also provide a wider range of products and competitive pricing, attracting a growing number of customers.

Local special circumstances: Switzerland has a high standard of healthcare and pharmaceutical regulation, which contributes to the strong growth of the analgesics market. The country's strict quality control measures ensure that analgesic products available in pharmacies meet the highest standards of safety and efficacy. This regulatory environment instills confidence in consumers and reinforces their preference for purchasing analgesics from pharmacies.

Underlying macroeconomic factors: The Swiss economy has been relatively stable, with a high standard of living and strong purchasing power among consumers. This economic stability has contributed to the growth of the analgesics market, as consumers are willing to spend on healthcare products and are increasingly conscious of their well-being. Additionally, the aging population in Switzerland has led to a higher demand for analgesics, as older individuals are more likely to experience chronic pain and seek pain relief products. In conclusion, the Analgesics (Pharmacies) market in Switzerland is experiencing steady growth due to customer preferences for pharmacy channels, the increasing demand for natural and alternative pain relief products, the popularity of online pharmacies, the country's high healthcare and pharmaceutical standards, and the stable macroeconomic factors.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.